- Home
- GROW vs GDTC Comparison
GROW vs GDTC Comparison
Compare GROW & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- GDTC
- Stock Information
- Founded
- GROW 1968
- GDTC 2018
- Country
- GROW United States
- GDTC Singapore
- Employees
- GROW N/A
- GDTC N/A
- Industry
- GROW Investment Managers
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- GDTC Health Care
- Exchange
- GROW Nasdaq
- GDTC Nasdaq
- Market Cap
- GROW 29.4M
- GDTC 28.0M
- IPO Year
- GROW N/A
- GDTC 2023
- Fundamental
- Price
- GROW $2.37
- GDTC $2.06
- Analyst Decision
- GROW
- GDTC Buy
- Analyst Count
- GROW 0
- GDTC 1
- Target Price
- GROW N/A
- GDTC $5.00
- AVG Volume (30 Days)
- GROW 33.6K
- GDTC 8.8K
- Earning Date
- GROW 05-08-2025
- GDTC 01-01-0001
- Dividend Yield
- GROW 3.80%
- GDTC N/A
- EPS Growth
- GROW N/A
- GDTC N/A
- EPS
- GROW 0.01
- GDTC N/A
- Revenue
- GROW $8,932,000.00
- GDTC $368,838.00
- Revenue This Year
- GROW N/A
- GDTC $5.37
- Revenue Next Year
- GROW N/A
- GDTC N/A
- P/E Ratio
- GROW $221.02
- GDTC N/A
- Revenue Growth
- GROW N/A
- GDTC N/A
- 52 Week Low
- GROW $2.02
- GDTC $1.20
- 52 Week High
- GROW $2.73
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- GROW 70.64
- GDTC 39.67
- Support Level
- GROW $2.16
- GDTC $2.21
- Resistance Level
- GROW $2.24
- GDTC $2.45
- Average True Range (ATR)
- GROW 0.06
- GDTC 0.12
- MACD
- GROW 0.02
- GDTC -0.00
- Stochastic Oscillator
- GROW 88.00
- GDTC 12.90
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.